ArticleJAMA network open2022

Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.

Sanjay Popat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.